Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation
Nicotine pouches have gained popularity as a smoke-free alternative to traditional cigarettes and vaping devices. Available in an array of flavours and brands like Zyn and Velo, these discreet pouches
By James Whitfield, Manufacturing & Supply Chain Writer
In today's world of modern medicine, finding effective treatments that offer relief for multiple conditions is invaluable. Hydroxyzine, a widely prescribed antihistamine, stands out not only for its v
By Priya Raghavan, Biotech & Markets Analyst
Advances in medical science have opened up incredible possibilities for treating and regenerating human skin. Stem cells, with their remarkable ability to develop into different types of cells, are at
By James Whitfield, Manufacturing & Supply Chain Writer
In recent years, one of the most pressing concerns in healthcare has been the rising threat of superbug resistance. These drug-resistant bacteria have evolved to outsmart many of the antibiotics that
By Priya Raghavan, Biotech & Markets Analyst
In the world of mathematics, there are certain formulas that act as essential tools for problem-solving. Among these, the quadratic formula holds a special place for its ability to solve equations tha
By Dr. Eleanor Vance, Regulatory Affairs Editor
The fight against melanoma, the deadliest form of skin cancer, has taken a revolutionary step forward with the introduction of a personalised vaccine now in clinical trials in Britain. This groundbrea
By Tom Okafor, Clinical Trials Correspondent
A new antibiotic compound known as zosurabalpin shows great promise in early studies against carbapenem-resistant Acinetobacter baumannii (CRAB), a dangerous superbug that causes severe infections and
By James Whitfield, Manufacturing & Supply Chain Writer
The pharmaceutical industry stands at the crossroads of human health and technological advancement. Imagine it as a high-stakes chessboard. The game has been around for a long time, but suddenly, the
By Priya Raghavan, Biotech & Markets Analyst
A Groundbreaking Leap for Kidney Health In the battle against kidney diseases, we've just reached a significant milestone that promises to transform lives. The stage is set, the players are aligned, a
By Priya Raghavan, Biotech & Markets Analyst
Cystic fibrosis, a condition often whispered about but seldom fully understood, is like a relentless storm cloud overshadowing the lives it touches. This inherited disease paints a challenging picture
By Priya Raghavan, Biotech & Markets Analyst
Introduction As the dust from the COVID-19 pandemic begins to settle, one industry that continues to command strong levels of public trust and favourability is pharmaceuticals. According to the third
By Dr. Eleanor Vance, Regulatory Affairs Editor
In an era where scientific innovation consistently pushes the boundaries of what's possible, the Weizmann Institute has unveiled a groundbreaking research development: an entity that bears a striking
By Dr. Eleanor Vance, Regulatory Affairs Editor
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy